PCSK9 inhibitor - Globe Thesis

Keyword [PCSK9 inhibitor] Result: 1 - 20 \| Page: 1 of 1
1.	Research Advanced In Emerging Drugs For Familial Hypercholesterolemia
2.	The Effects Of Pep2-8 Trifluoroacetate Salt On Focal Cerebral Ischemia/Reperfusion Injury By Regulating TLR4/NF-κB Signaling Pathway In Rat
3.	Meta-analysis Of The Effect Of Statins Combined With PCSK9 Inhibitor Evolocumab On Lipid Metabolism
4.	The Short-term Lipid-lowering Efficacy And Safety Analysis Of PCSK9 Inhibitor Evolocumab In Extremely High-risk Patients With Acute Coronary Syndrome
5.	Effect Of PCSK9 Inhibitor On Triglyceride Of Various Level
6.	The Research On The Protective Effect And Mechanism Of Pcsk9 Inhibitor On Hypoxic Cardiomyocytes
7.	A New Hope For Cardiovascular Diseases-PCSK9 Inhibitor
8.	Protective Effects Of PCSK9 Inhibitor In Rats With Myocardial Ischemia/reperfusion Injury
9.	Effects Of PCSK9 Inhibitors On Lipids And Prognosis In Patients With ACS
10.	Efficacy Of PCSK9 Inhibitor Combined With Statins In The Treatment Of ASCVD Super-high Risk Population
11.	The Effect Of PCSK9 Inhibitor On Low Density Lipoprotein Cholesterol,hs-CRP And NLR Levels In Patients With Acute Coronary Syndrome
12.	A Clinical Study Of The Effect Of PCSK9 Inhibitor In Ultra-high Risk ASCVD With Percutaneous Coronary Intervention Patients
13.	Effect Of PCSK9 Inhibitor Evolocumab On The Degree Of Coronary Artery Stenosis In Patients With Coronary Heart Disease
14.	Effectiveness Of PCSK9 Inhibitors In Improving Inflammation In Patients With Coronary Heart Disease
15.	Effect Of Early Application Of PCSK9 Inhibitor On Slow/No-reflow During PCI In ACS Patients
16.	The Effects Of PCSK9 Inhibitors On Major Adverse Cardiac Events And Lipoprotein(a) In Patients With Coronary Heart Disease:A Meta-analysis
17.	The Clinical Efficacy Of PCSK9 Inhibitor(Alirocumab) In The Treatment Of Hyperlipidemia With Carotid Plaque
18.	A Comparative Study Of The Effect Of PCSK9 Inhibitors On Bleeding And Coagulation In Patients After Percutaneous Coronary Intervention
19.	The Observation Of The Early Efficacy Of PCSK9 Inhibitors-Evolocumab In Ultra-high-risk ACS Patients
20.	Clinical Observation Of PCSK9 Inhibitor In Patients With Acute Coronary Syndrome
<<First <Prev Next> Last>> Jump to